Molecular basis of pimarane compounds as novel activators of large-conductance Ca2+-activated K+ channel α-subunit

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 836-846

  Imaizumi, Yuji ^a   Sakamoto, Kazuho ^a   Yamada, Aki ^a   Hotta, Aya ^a   Ohya, Susumu ^a   Muraki, Katsuhiko ^a   Uchiyama, Masanobu ^a,b   Ohwada, Tomohiko ^a,b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABIETIC ACID; BIS(1,3 DIBUTYLBARBITURIC ACID)TRIMETHINE OXONOL; CALCIUM ION; CHARYBDOTOXIN; DIHYDROISOPIMARIC ACID; DIHYDROISOPIMARINOL; DIHYDROPIMARIC ACID; FLUORESCENT DYE; ISOPIMARIC ACID; METHYLPIMARATE; PIMARANE DERIVATIVE; PIMARIC ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; SANDARACOISOPIMARIC ACID; SCLAREOL; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG CONFORMATION; EMBRYO; HUMAN; HUMAN CELL; HYPERPOLARIZATION; KIDNEY CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VOLTAGE CLAMP;

CELLS, CULTURED; DITERPENES; DITERPENES, ABIETANE; ELECTROPHYSIOLOGY; FREE RADICAL SCAVENGERS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; PHENANTHRENES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN SUBUNITS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0036784042     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.836     Document Type: Article

References (39)

1. + channel α-and β-subunits in HEK293 cells. FEBS Lett 415:67-70.
2. Brenner R, Jegla TJ, Wickenden A, Liu Y, and Aldrich RW (2000a) Cloning and functional characterization of novel large conductance calcium -activated potassium channel β subunits, hKCNMB3 and hKCNMB4. J Biol Chem 275:6453-6461.
3. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW (2000b) Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature (Lond) 407:870-876.
4. + channels by the muscle relaxant chlorzoxazane and structurally related compounds. J Pharmacol Exp Ther 296:683-689.
5. Coghlan MJ, Carroll WA, and Gopalakrishnan M (2001) Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 44:1627-1653.
6. 2+ sensitivity. J Gen Physiol 116:411-432.
7. Dick GM, Rossow CF, Smirnov S, Horowitz B, and Sanders KM (2001) Tamoxifen activates smooth muscle BK channels through the regulatory β1 subunit. J Biol Chem 276:34594-34599.
8. 4(3)) in model systems and cells. Chem Phys Lipids 69:137-150.
9. Fukao M, Mason HS, Kenyon JL, Horowitz B, and Keef KD (2001) Regulation of BKCa channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59:16-23.
10. Garcia-Calvo M, Knaus HG, McManaus OG, Giangiacomo, KM Kaczorowski GJ, Garcia ML (1994) Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem 268:676-682.
11. Giangiacomo KM, Kamassah A, Harris G, and McManus OB (1998) Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 112:485-501.
12. Gonzalez JE, Oades, Leychkis Y, Harootunian A, Negulescu PA (1999) Cell-based assays and instrumentation for screening ion-channel targets. Drug Discov Today 4:431-439.
13. Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nature (Lond) Med 7:471-477.
14. + current and contractile system in some types of smooth muscle cells. Am J Physiol 271:C781-C791.
15. + current during depolarization in smooth muscles cells of the guinea-pig vas deferens and urinary bladder. J Physiol 510:705-719.
16. Jaggar JH, Porter VA, Lederer WJ, and Nelson MT (2000) Calcium sparks in smooth muscle. Am J Physiol 278:C235-C256.
17. + channel. Am J Physiol 275:C848-C856.
18. Kaczorowski GJ and Garcia ML (1999) Pharmacology of voltage-gated and calcium-activated potassium channels. Curr Opin Chem Biol 3:448-458.
19. + channel from smooth muscle. J Biol Chem 269:17274-17278.
20. Lawson K (2000) Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin Investig Drugs 9:2269-2280.
21. Lee SH, Hensens OD, Helms GL, Liesch JM, Zink DJ, Giacobbe RA, Bills GF, Stevens-Miles S, Garcia ML, Schmalhofer WA et al. (1995) L-735,334, a novel sesquiterpenoid potassium channel-agonist from Trichoderma virens. J Nat Prod 58:1922-1828.
22. + channels in aorta of hypertensive rats. Hypertension 30:1403-1409.
23. McManus OB, Harris GH, Giangiacomo KM, Feigebaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ, and Garcia ML (1993) An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32:6128-6133.
24. McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, and Leonard RJ (1995) Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron 14:645-650.
25. + channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci USA 97:5562-5567.
26. + channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), and extracellular N terminus and an intracellular (S9-S10) C terminus. Proc Natl Acad Sci USA 94:14066-14071.
27. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, and Lederer WJ (1995) Relaxation of arterial smooth muscle by calcium sparks, Science (Wash DC) 270:633-637.
28. 2+ transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol 534:313-326.
29. Plasek J and Sigler K (1996) Slow fluorescent indicators of membrane potential: a survey of different approaches to probe response analysis. J Photochem Photobiol B Biol 33:101-124.
30. Schreiber M and Salkoff L (1997) A novel calcium-sensing domain in BK channel. Biophys J 73:1355-1363.
31. Shieh CC, Coghlan MC, Sullivan JP, and Gopalakrishnan M (2000) Potassium channels: Molecular defects, diseases and therapeutic opportunities. Pharmacol Rev 52:557-593.
32. Singh SB, Goetz MA, Zink DL, Dombrowski AW, Polishook JD, Garcia ML, Schmalhofer W, McManus OB, and Kaczorowski GJ (1994) Maxikdiol: a novel dihydroxyisoprimane as an agonist of maxi-K channels. J Chem Soc Perkin Trans 1:3349-3352.
33. Starrett JE, Dworetzky SI, and Gibkoff VK (1996) Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Current Pharmaceut Design 2:413-428.
34. + channel. J Biol Chem 275:23211-23218.
35. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, and Latorre R (1999) Acute activation of Maxi-K channels (hSlo) by estradiol binding to the β subunit. Science (Wash DC) 285:1929-1931.
36. Vergara C, Latorre R, Marrion N, and Adelman JP (1998) Calcium-activated potassium channels. Current Opin Neurobiol 8:321-329.
37. + channels: an additional transmembrane region at the N terminus. Proc Natl Acad Sci USA 93:14922-14927.
38. 2+-activated, voltage-dependent BK currents: consequences of rapid inactivation by a novel β subunit. J Neurosci 20:4890-4903.
39. + channels in HEK293 cells. Jpn J Pharmacol 86:342-350.